Calumet Specialty Products
CLMT
62 hedge funds and large institutions have $214M invested in Calumet Specialty Products in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 24 increasing their positions, 10 reducing their positions, and 7 closing their positions.
140% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 10
106% more call options, than puts
Call options by funds: $22.5M | Put options by funds: $10.9M
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
28% more capital invested
Capital invested by funds: $167M → $214M (+$47M)
0.69% more ownership
Funds ownership: 20.37% → 21.07% (+0.69%)
3% less funds holding
Funds holding: 64 → 62 (-2)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$4.46M |
| 2 |
WWM
Windsor Wealth Management
Indianapolis,
Indiana
|
+$4.3M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$1.67M |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$1.65M |
| 5 |
PI
PEAK6 Investments
Chicago,
Illinois
|
+$1.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EGA
Evermore Global Advisors
Summit,
New Jersey
|
-$8.11M |
| 2 |
Goldman Sachs
New York
|
-$1.08M |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$719K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$502K |
| 5 |
Jane Street
New York
|
-$336K |
CLMT Hedge Fund Activity: Q3 2022 in Review
62 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Calumet Specialty Products (CLMT) for Q3 2022, worth a combined $214M — up 28% from $167M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CLMT and 6 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 24 added.
The largest buyer was Morgan Stanley, adding an estimated $4.46M. The largest seller was Evermore Global Advisors, cutting an estimated $8.11M.
- 62 institutional investors held Calumet Specialty Products (CLMT) as of Q3 2022, down from 64 in Q2 2022.
- Funds reported $214M of Calumet Specialty Products stock for Q3 2022, up 28% quarter-over-quarter.
- 6 funds opened new Calumet Specialty Products positions in Q3 2022 and 7 closed out, a net change of -1 holder.
- The largest Calumet Specialty Products buyer in Q3 2022 was Morgan Stanley, an estimated $4.46M added.
- The largest Calumet Specialty Products seller in Q3 2022 was Evermore Global Advisors, an estimated $8.11M sold.
Based on aggregated 13F filings for Q3 2022.